We are live on ! Find out more

Fund managers haven’t disclosed any holdings of IMNN yet.

IMNN Hedge Fund Activity: Q1 2026 in Review

19 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Imunon (IMNN) for Q1 2026, worth a combined $1.63M — down 7.7% from $1.76M a quarter earlier.

Fund positioning in IMNN was balanced in Q1 2026: 3 funds opened new positions, 3 closed out, 6 added to existing stakes and 3 trimmed.

The largest buyer was Armistice Capital, adding an estimated $268K. The largest seller was DRW Securities, exiting entirely with an estimated $224K sold.

  • 19 institutional investors held Imunon (IMNN) as of Q1 2026, down from 20 in Q4 2025.
  • Funds reported $1.63M of Imunon stock for Q1 2026, down 7.7% quarter-over-quarter.
  • 3 funds opened new Imunon positions in Q1 2026 and 3 closed out, a net change of 0 holders.
  • The largest Imunon buyer in Q1 2026 was Armistice Capital, an estimated $268K added.
  • The largest Imunon seller in Q1 2026 was DRW Securities, an estimated $224K sold.

Based on aggregated 13F filings for Q1 2026.